COMMUNIQUÉS West-GlobeNewswire

Avid Bioservices to Participate at Upcoming CDMO Industry Conferences
13/03/2018
TUSTIN, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by [...]
Genedrive PLC: Commercial sales of Genedrive® HCV ID Kit and platform begin
13/03/2018
13 March 2018 genedrive plc ("genedrive" or the "Company") Commercial sales of Genedrive® HCV ID Kit and platform begin Decentralised molecular HCV assays shipped to Africa genedrive plc (AIM: GDR), the near patient [...]
Healthwise and GetWellNetwork Partner to Deliver Award-Winning Health Education
13/03/2018
BOISE, Idaho, March 13, 2018 (GLOBE NEWSWIRE) -- Healthwise and GetWellNetwork ® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over [...]
CrownBio Enters Strategic Partnership with Phanes Therapeutics to Accelerate Discovery and Development of Phanes’ Novel Oncology Agents
13/03/2018
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Tauriga Sciences Inc. Purchases Shares of Virginia Based NASDAQ Listed Company Focused on Nuclear Fuel Technology Development
13/03/2018
NEW YORK, NY , March 13, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of [...]
Caladrius Biosciences Doses First Patient with CLBS12 in Phase 2 Critical Limb Ischemia Trial in Japan
13/03/2018
BASKING RIDGE, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Rexahn Pharmaceuticals to Present at Two Upcoming Conferences
13/03/2018
B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS) on March 16 Oppenheimer 28th Annual Healthcare Conference on March 21 ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Rexahn [...]
Biotricity Appoints Casey Shattuck as New VP of Sales to Spearhead Bioflux Launch
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring [...]
MannKind Announces STAT Study Results Accepted for Presentation at American Diabetes Association’s 78th Scientific Sessions
13/03/2018
WESTLAKE VILLAGE, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ) focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]
Avinger Provides Update on U.S. Intellectual Property Portfolio
13/03/2018
REDWOOD CITY, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced three recent additions to its U.S [...]
RavenQuest Completes Final Tranche of Financing
13/03/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS VANCOUVER, British Columbia, March [...]
AIT Therapeutics Announces Year End 2017 Financial Results Conference Call and Webcast
13/03/2018
Call Scheduled for Monday, March 19, 2018 at 4:30pm Eastern Time. NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]
Annual General Meeting 2018 – GN Store Nord A/S
13/03/2018
Today, GN Store Nord A/S held its annual general meeting in accordance with the agenda announced on February 19, 2018. The report by the board of directors was adopted, and both the Annual Report 2017 and the proposal [...]
Checkpoint Therapeutics to Participate in March Investor Conferences
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
Mustang Bio to Present at March Investor Conferences
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Fortress Biotech to Present at Oppenheimer’s 28th Annual Healthcare Conference
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]
Fluidigm Announces Exchange of Convertible Notes
13/03/2018
SOUTH SAN FRANCISCO, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that it has entered into separate privately negotiated transactions to exchange approximately $25.0 [...]
Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer
13/03/2018
Dr. Almenoff brings more than 20 years of pharmaceutical executive experience from GlaxoSmithKline and from Furiex Pharmaceuticals, where as President and Chief Medical Officer, she oversaw the development of Viberzi [...]
OpGen Announces Collaborator in Verification Study for Acuitas® Test
13/03/2018
GAITHERSBURG, Md., March 13, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announced today that it is collaborating with Beth Israel Deaconess Medical Center (BIDMC) in Boston on a verification study for OpGen’s [...]

Pages